Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00134017 · OUTCOME

Days to Engraftment

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer · Source last updated 2018-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
days
Interval / dispersion
Full Range
Time frame
Up to one year

What was measured

Median number of days to neutrophil and platelet engraftment.

Analysis population: The study data was analyzed early after 117 participants had been treated. This was done in order to publish the data and establish a new local standard of care at our institution. Engraftment data was not collected on the remaining 25 participants. Recipients of related-donor (n=78) and unrelated-donor (n=39) transplants were reported separately.

Groups in this outcome

Bone Marrow Transplant

Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant117

Reported measurements

Neutrophil engraftment, related donors

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant78
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant23Not reported2100Not reported
Neutrophil engraftment, unrelated donors

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant39
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant25Not reported2100Not reported
Platelet engraftment, related donors

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant78
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant31Not reported5354Not reported
Platelet engraftment, unrelated donors

Analysis denominator · Participants

GroupSource count
Bone Marrow Transplant39
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Bone Marrow Transplant35Not reported5354Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2
        upper Limit
        100
        value
        23
    denoms
    1. counts
      1. group Id
        OG000
        value
        78
      units
      Participants
    title
    Neutrophil engraftment, related donors
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2
        upper Limit
        100
        value
        25
    denoms
    1. counts
      1. group Id
        OG000
        value
        39
      units
      Participants
    title
    Neutrophil engraftment, unrelated donors
  3. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        5
        upper Limit
        354
        value
        31
    denoms
    1. counts
      1. group Id
        OG000
        value
        78
      units
      Participants
    title
    Platelet engraftment, related donors
  4. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        5
        upper Limit
        354
        value
        35
    denoms
    1. counts
      1. group Id
        OG000
        value
        39
      units
      Participants
    title
    Platelet engraftment, unrelated donors
denoms
  1. counts
    1. group Id
      OG000
      value
      117
    units
    Participants
description
Median number of days to neutrophil and platelet engraftment.
dispersion Type
Full Range
groups
  1. description
    Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.
    id
    OG000
    title
    Bone Marrow Transplant
param Type
MEDIAN
population Description
The study data was analyzed early after 117 participants had been treated. This was done in order to publish the data and establish a new local standard of care at our institution. Engraftment data was not collected on the remaining 25 participants. Recipients of related-donor (n=78) and unrelated-donor (n=39) transplants were reported separately.
reporting Status
POSTED
time Frame
Up to one year
title
Days to Engraftment
type
SECONDARY
unit Of Measure
days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice